Zimmer Biomet Responds to FDA Form 483
Zimmer Biomet published a response to the Form 483 issued by FDA in April 2018, related to inspectional observations at the...
Zimmer Biomet published a response to the Form 483 issued by FDA in April 2018, related to inspectional observations at the...
To meet your need to know who's new in the orthopaedic market, I sorted through the 21 companies receiving their...
Safe Orthopaedics entered into an exclusive commercialization and distribution agreement in Japan with KiSCO....
Implanet opened a branch in the U.K. to support expansion and growth in the adult degenerative spine market. ...
In August 2014, we published a list of companies that we thought were at the forefront of fracture repair. Were...
BONESUPPORT entered into an agreement with Collagen Matrix on U.S. sales of bone graft substitute products through its own U.S. distribution network, beginning...
BONESUPPORT will create its own U.S. commercial organization to support current and future U.S. product launches. Direct sales will commence in October...
FDA performed an inspection of Zimmer Biomet's Warsaw North Campus manufacturing facility in April 2018, and issued a Form 483 with...
DePuy Synthes entered into an exclusive agreement to promote Prosidyan's FIBERGRAFT® synthetic bone graft in spinal fusion, starting in 2Q18....
Episurf Medical entered into a distribution agreement in Hong Kong and established a U.S. subsidiary to conduct clinical studies for devices to...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.